93 related articles for article (PubMed ID: 20886456)
21. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
Kanda T; Kitajima K; Suenaga Y; Konishi J; Sasaki R; Morimoto K; Saito M; Otsuki N; Nibu K; Sugimura K
Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295
[TBL] [Abstract][Full Text] [Related]
22. FDG PET and PET/CT imaging in lymphoma and melanoma.
Macapinlac HA
Cancer J; 2004; 10(4):262-70. PubMed ID: 15383207
[TBL] [Abstract][Full Text] [Related]
23. FDG-PET and PET/CT in malignant lymphoma.
Reske SN
Recent Results Cancer Res; 2008; 170():93-107. PubMed ID: 18019620
[No Abstract] [Full Text] [Related]
24. PET/CT in malignant lymphoma: basic information, clinical application, and proposal.
Tateishi U
Int J Hematol; 2013 Oct; 98(4):398-405. PubMed ID: 24065513
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography imaging for lymphoma.
Jerusalem G; Hustinx R; Beguin Y; Fillet G
Curr Opin Oncol; 2005 Sep; 17(5):441-5. PubMed ID: 16093792
[TBL] [Abstract][Full Text] [Related]
26. Importance of [18F]fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma.
Baudard M; Comte F; Conge AM; Mariano-Goulart D; Klein B; Rossi JF
Leuk Lymphoma; 2007 Feb; 48(2):381-8. PubMed ID: 17325900
[TBL] [Abstract][Full Text] [Related]
27. FDG PET/CT methodology for evaluation of treatment response in lymphoma: from "graded visual analysis" and "semiquantitative SUVmax" to global disease burden assessment.
Basu S; Zaidi H; Salavati A; Hess S; Carlsen PF; Alavi A
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2158-60. PubMed ID: 24993455
[No Abstract] [Full Text] [Related]
28. Lymphoma imaging: nuclear medicine.
Kostakoglu L; Goldsmith SJ
Cancer Treat Res; 2006; 131():363-412. PubMed ID: 16704177
[No Abstract] [Full Text] [Related]
29. [Value of positron emission tomography in urological neoplasms: more form than substance?].
Müller J; Schrader M; Schrader AJ; Höpfner M; Zengerling F
Urologe A; 2012 Mar; 51(3):331-40. PubMed ID: 22358377
[TBL] [Abstract][Full Text] [Related]
30. The SUV and FLT PET: a tasty alphabet soup or a dog's breakfast?
Hicks RJ
Leuk Lymphoma; 2007 Apr; 48(4):649-52. PubMed ID: 17454619
[No Abstract] [Full Text] [Related]
31. Refractory Burkitt Lymphoma With False-positive and False-negative Mass Detected on Positron Emission Tomography-computed Tomography After Chemotherapy.
Shima H; Takaki T; Ito J; Iwabuchi Y; Nakazawa A; Shimada H
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e915-e916. PubMed ID: 37526341
[TBL] [Abstract][Full Text] [Related]
32. [New trends and novel possibilities in the diagnosis of lymphomas].
Illés Á; Simon Z
Magy Onkol; 2015 Mar; 59(1):73-8. PubMed ID: 25763917
[TBL] [Abstract][Full Text] [Related]
33. Variable problems in lymphomas: CASE 2. Sarcoidosis mimicking progressive lymphoma.
Hollister D; Lee MS; Eisen RN; Fey C; Portlock CS
J Clin Oncol; 2005 Nov; 23(31):8113-6. PubMed ID: 16258110
[No Abstract] [Full Text] [Related]
34. PET in lymphoma.
Collins CD
Cancer Imaging; 2006 Oct; 6(Spec No A):S63-70. PubMed ID: 17114080
[TBL] [Abstract][Full Text] [Related]
35. [Role of positron emission tomography in the clinical practices and trials for malignant lymphoma].
Rinsho Ketsueki; 2008 Mar; 49(3):153-8. PubMed ID: 18421955
[No Abstract] [Full Text] [Related]
36. Can diffusion-weighed whole-body magnetic resonance imaging with body signal suppression play a role in the management of lymphoma patients?
Minoia C; Maggialetti N; Ferrari C; Brunese L; Rubini G; Guarini A
J BUON; 2016; 21(1):282-3. PubMed ID: 27061563
[No Abstract] [Full Text] [Related]
37. Can a positive positron emission tomography scan be positive news?
Wooldridge JE
Leuk Lymphoma; 2007 Feb; 48(2):227-8. PubMed ID: 17325881
[No Abstract] [Full Text] [Related]
38. What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?
Gill S; Hicks RJ; Seymour JF
Leuk Lymphoma; 2008 Sep; 49(9):1653-6. PubMed ID: 18798097
[No Abstract] [Full Text] [Related]
39. Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma: A Report of 11 Cases Correlating Clinicopathologic and Radiologic Findings.
Fang H; Chuang HH; Strati P; Hu S; Shuai W; Medeiros LJ; Wang W
Am J Surg Pathol; 2021 Feb; 45(2):160-168. PubMed ID: 32769427
[TBL] [Abstract][Full Text] [Related]
40. Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?
Boellaard R; Kobe C; Zijlstra JM; Mikhaeel NG; Johnson PWM; Müller S; Dührsen U; Hoekstra OS; Barrington S
J Nucl Med; 2018 Jul; 59(7):1167-1169. PubMed ID: 29626118
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
